Posts

Showing posts with the label B-cell Maturation Antigen (BCMA) Targeted Therapies

Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

B-cell Maturation Antigen (BCMA) Targeted Therapies Market Overview and Industry growth factors

Image
Multiple myeloma (MM) is a clonal plasma cell malignant tumour that develops in the bone marrow's soft, spongy tissue. Plasma cells are an important component of the immune system that aids in the battle against infections and other disorders. Low blood counts, renal failure, hypercalcemia, immunological suppression, monoclonal gammopathy, and anaemia are all symptoms of multiple myeloma, a malignancy caused by malignant plasma cells.   Market Overview         B cell maturation antigen targeted therapies Market for novel MM immunotherapy and is involved in the pathophysiology of the disease. Complete responses have been documented in strongly pretreated MM patients after treatment with B cell maturation antigen antibody-drug conjugates (ADC), bi-specific T cell engagers, and chimeric antigen receptor T. These and other BCMA-targeted medicines are changing the face of MM treatment and patient outcomes. The CAR T-cell method has been used t...

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Malaria Vaccines Market – Making Way for a Malaria-Free World

Global and China Catheter Market Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027